Ahmed-Amine Anzali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed-Amine Anzali has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Sayadi
Centre de Recherche Sur L’inflammation, Université Paris-Cité, Inserm, UMR 1149, Paris, France
33 shared publications - Alix Marhic
Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Institut Gustave Roussy, Rue Edouard Vaillant, 94805 Villejuif, France
33 shared publications - Anne Auperin
Gustave Roussy 4 Biostatistics and Epidemiology Office Inserm U1018 Oncostat, Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France
33 shared publications - Antoine Moya-Plana
Department of Head and Neck Oncology, Institut Gustave Roussy, REFCOR, 94805 Villejuif, France
33 shared publications - Antonin Marchais
BiiOSTeam, INSERM U1360 Biology for Therapeutics in Resistant Pediatric Cancers, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France
33 shared publications - Camille Blériot
Université Paris-Saclay, Gustave Roussy, U1356 Next Generation Immuno-Oncology research, Villejuif, France
33 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Video S1 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Representative video of an isolated MGC in oral cavity SCC from GR cohort
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video S1 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Representative video of an isolated MGC in oral cavity SCC from GR cohort
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Videos Legends from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Legends of the two videos S1 and S2
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Videos Legends from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Legends of the two videos S1 and S2
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1 to S7 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Clinical Tables and Statistical Analyses
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1 to S7 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Clinical Tables and Statistical Analyses
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
CosMx 64-plex human immuno-oncology protein panel
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
CosMx 64-plex human immuno-oncology protein panel
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Association between keratin, MGC and clinical outcome
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Association between keratin, MGC and clinical outcome
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Microscopic visualization of MGC
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Microscopic visualization of MGC
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Performances of the deep-learning cell detection model in TCGA cohorts (oral cavity, uterine cervix and larynx SCC) and GR cohorts (oral cavity SCC)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Performances of the deep-learning cell detection model in TCGA cohorts (oral cavity, uterine cervix and larynx SCC) and GR cohorts (oral cavity SCC)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Pathological response to induction chemotherapy
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Pathological response to induction chemotherapy
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Immunohistochemistry for representative Visium markers
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
Immunohistochemistry for representative Visium markers
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
CosMx protein panel showing stainings in MGC
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma
CosMx protein panel showing stainings in MGC